U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Endometrial endometrioid adenocarcinoma

MedGen UID:
234467
•Concept ID:
C1336905
•
Neoplastic Process
Synonyms: Endometrial Endometrioid Adenocarcinoma; endometrial endometrioid adenocarcinoma; Endometrial Endometrioid Carcinoma; Endometrioid Adenocarcinoma of Endometrium; endometrioid adenocarcinoma of endometrium; Endometrioid Adenocarcinoma of the Endometrium; endometrioid adenocarcinoma of the endometrium; Endometrioid carcinoma of endometrium; Endometrioid Carcinoma of Endometrium; endometrioid carcinoma of endometrium; Endometrioid Carcinoma of the Endometrium; endometrioid carcinoma of the endometrium; endometrioid endomet. adenocar.; endometrioid endometrial adenocarcinoma; Uterine Corpus Endometrioid Adenocarcinoma; uterine corpus endometrioid adenocarcinoma; Uterine Corpus Endometrioid Carcinoma; uterine corpus endometrioid carcinoma; uterine endometrioid carcinoma
SNOMED CT: Endometrial endometrioid adenocarcinoma (1260086007); Endometrioid carcinoma of endometrium (1260086007)
 
Monarch Initiative: MONDO:0006192

Definition

A primary endometrial adenocarcinoma composed of neoplastic cells that form complex glandular patterns associated with budding and branching of the neoplastic glands. The neoplastic glands resemble those of the normal endometrium and may or may not be associated with sheet-like proliferation of malignant cells. Endometrioid adenocarcinoma is the most commonly seen morphologic variant of endometrial adenocarcinoma. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVEndometrial endometrioid adenocarcinoma

Professional guidelines

PubMed

The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary.
Gama Q, Luo S, Wu P, Wang L, Liu S, Zhang H, Sun L, Wang Y, Yu M, Chen X, Shan W, Luo X
J Ovarian Res 2023 Dec 8;16(1):235. doi: 10.1186/s13048-023-01316-w. PMID: 38062462Free PMC Article
Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
Montes de Oca MK, Albright BB, Secord AA, Havrilesky LJ, Moss HA
Int J Gynecol Cancer 2021 Dec;31(12):1549-1556. Epub 2021 Nov 1 doi: 10.1136/ijgc-2021-002884. PMID: 34725205
Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol.
Fernandez-Montoli ME, Sabadell J, Contreras-Perez NA
Adv Ther 2021 May;38(5):2717-2731. Epub 2021 Apr 8 doi: 10.1007/s12325-021-01693-y. PMID: 33830463

Recent clinical studies

Etiology

Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma.
Sugiyama Y, Gotoh O, Fukui N, Tanaka N, Hasumi K, Takazawa Y, Noda T, Mori S
Am J Pathol 2020 Jan;190(1):234-251. Epub 2019 Nov 13 doi: 10.1016/j.ajpath.2019.09.022. PMID: 31733184
BMI and Odds of Endometrial Adenocarcinoma in Czech Women - a Case Control Study.
Tichý M, Ptáčková H, Plančíková D, Majdan M, Chodacká M
Klin Onkol 2019 Summer;32(4):281-287. doi: 10.14735/amko2019281. PMID: 31426644
Endometrium and steroids, a pathologic overview.
Plaza-Parrochia F, Romero C, Valladares L, Vega M
Steroids 2017 Oct;126:85-91. Epub 2017 Aug 18 doi: 10.1016/j.steroids.2017.08.007. PMID: 28827068
Morphological, imaging and surgical aspects in endometrial endometrioid adenocarcinoma.
Berceanu C, Stepan AE, MehedinŢu C, Cîrstoiu MM, Ciortea R, Berceanu S, Gheonea IA, Brătilă E
Rom J Morphol Embryol 2016;57(3):995-1002. PMID: 28002515
Food intake and the risk of endometrial endometrioid adenocarcinoma in Japanese women.
Takayama S, Monma Y, Tsubota-Utsugi M, Nagase S, Tsubono Y, Numata T, Toyoshima M, Utsunomiya H, Sugawara J, Yaegashi N
Nutr Cancer 2013;65(7):954-60. Epub 2013 Sep 20 doi: 10.1080/01635581.2013.818158. PMID: 24053697

Diagnosis

YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia/ intraepithelial neoplasia.
Bian PP, Liu SY, Luo QP, Xiong ZT
Pathol Res Pract 2022 Jun;234:153919. Epub 2022 Apr 28 doi: 10.1016/j.prp.2022.153919. PMID: 35512522
Low grade endometrial endometrioid adenocarcinoma: A review and update with emphasis on morphologic variants, mimics, immunohistochemical and molecular features.
Lucas E, Carrick KS
Semin Diagn Pathol 2022 May;39(3):159-175. Epub 2022 Feb 11 doi: 10.1053/j.semdp.2022.02.002. PMID: 35397943
RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S, Lin M, Ji H, Ding J, Zhu J, Ma R, Meng F
Diagn Pathol 2019 Jan 26;14(1):7. doi: 10.1186/s13000-019-0784-6. PMID: 30684972Free PMC Article
Endometrium and steroids, a pathologic overview.
Plaza-Parrochia F, Romero C, Valladares L, Vega M
Steroids 2017 Oct;126:85-91. Epub 2017 Aug 18 doi: 10.1016/j.steroids.2017.08.007. PMID: 28827068
Morphological, imaging and surgical aspects in endometrial endometrioid adenocarcinoma.
Berceanu C, Stepan AE, MehedinŢu C, Cîrstoiu MM, Ciortea R, Berceanu S, Gheonea IA, Brătilă E
Rom J Morphol Embryol 2016;57(3):995-1002. PMID: 28002515

Therapy

The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
Ou YC, Fu HC, Lan J, Wu CH, Kung FT, Lan KC, Tsai YC, Lin H
Eur J Obstet Gynecol Reprod Biol 2021 Dec;267:99-104. Epub 2021 Oct 29 doi: 10.1016/j.ejogrb.2021.10.026. PMID: 34739876
The Safety of Ovarian Preservation in Stage I Endometrial Endometrioid Adenocarcinoma Based on Propensity Score Matching.
Hou T, Sun Y, Li J, Liu C, Wang Z, Li Y, Lu Y
Comb Chem High Throughput Screen 2017;20(7):647-655. doi: 10.2174/1386207320666170417145856. PMID: 28413975
Circulating microRNAs as a fingerprint for endometrial endometrioid adenocarcinoma.
Wang L, Chen YJ, Xu K, Xu H, Shen XZ, Tu RQ
PLoS One 2014;9(10):e110767. Epub 2014 Oct 20 doi: 10.1371/journal.pone.0110767. PMID: 25329674Free PMC Article
Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
Rubatt JM, Slomovitz BM, Burke TW, Broaddus RR
Gynecol Oncol 2005 Nov;99(2):472-6. Epub 2005 Aug 15 doi: 10.1016/j.ygyno.2005.06.050. PMID: 16099019
Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade.
Khin EE, Kikkawa F, Ino K, Kajiyama H, Suzuki T, Shibata K, Tamakoshi K, Nagasaka T, Mizutani S
Am J Obstet Gynecol 2003 Mar;188(3):670-6. doi: 10.1067/mob.2003.169. PMID: 12634639

Prognosis

The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
Ou YC, Fu HC, Lan J, Wu CH, Kung FT, Lan KC, Tsai YC, Lin H
Eur J Obstet Gynecol Reprod Biol 2021 Dec;267:99-104. Epub 2021 Oct 29 doi: 10.1016/j.ejogrb.2021.10.026. PMID: 34739876
Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma.
Sugiyama Y, Gotoh O, Fukui N, Tanaka N, Hasumi K, Takazawa Y, Noda T, Mori S
Am J Pathol 2020 Jan;190(1):234-251. Epub 2019 Nov 13 doi: 10.1016/j.ajpath.2019.09.022. PMID: 31733184
RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S, Lin M, Ji H, Ding J, Zhu J, Ma R, Meng F
Diagn Pathol 2019 Jan 26;14(1):7. doi: 10.1186/s13000-019-0784-6. PMID: 30684972Free PMC Article
Cyclins A, B, E and p27 in Endometrial Endometrioid Adenocarcinoma.
Santala S, Talvensaari-Mattila A, Soini Y, Kuvaja P, Santala M
Anticancer Res 2016 Dec;36(12):6467-6473. doi: 10.21873/anticanres.11245. PMID: 27919969
Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications.
Cole AJ, Quick CM
Adv Anat Pathol 2013 May;20(3):141-7. doi: 10.1097/PAP.0b013e31828d17cc. PMID: 23574770

Clinical prediction guides

The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
Ou YC, Fu HC, Lan J, Wu CH, Kung FT, Lan KC, Tsai YC, Lin H
Eur J Obstet Gynecol Reprod Biol 2021 Dec;267:99-104. Epub 2021 Oct 29 doi: 10.1016/j.ejogrb.2021.10.026. PMID: 34739876
Construction and validation of nomograms for predicting the prognosis of grade 3 endometrial endometrioid adenocarcinoma cancers: a SEER-based study.
Liu X, Zhao J, Sun Z, Wang G
Bioengineered 2021 Dec;12(1):1752-1765. doi: 10.1080/21655979.2021.1922247. PMID: 33975518Free PMC Article
Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy.
Reshko LB, Gaskins JT, Dryden SM, Metzinger DS, Todd SL, Eldredge-Hindy HB, Silva SR
Int J Gynecol Cancer 2021 May;31(5):694-701. Epub 2021 Mar 19 doi: 10.1136/ijgc-2021-002380. PMID: 33741653
RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S, Lin M, Ji H, Ding J, Zhu J, Ma R, Meng F
Diagn Pathol 2019 Jan 26;14(1):7. doi: 10.1186/s13000-019-0784-6. PMID: 30684972Free PMC Article
IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.
Mhawech-Fauceglia P, Herrmann FR, Rai H, Tchabo N, Lele S, Izevbaye I, Odunsi K, Cheney RT
Am J Clin Pathol 2010 Jun;133(6):899-908. doi: 10.1309/AJCPQDQXJ4FNRFQB. PMID: 20472848

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...